entertainment -WSS

entertainment

author：entertainment 2025-09-30 11:06:51 - browse：72

Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Roche drug slashes death risk in early

hotspot

WSS

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Readout LOUD podcast: Live from the 2023 STAT Summit

Results on Novartis prostate cancer therapy could expand its use

Ionis has late

Results on Novartis prostate cancer therapy could expand its use

focus

entertainment

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

STAT Readout: Friday, Oct. 20 biotech updates

At least 13 dead in Texas as scorching temps continue

STAT Readout Newsletter: Biotech news today

The high cost of giving birth even with insurance

Roivant's CEO is a star, but biotech's black hole persists

Medical leaders decry Supreme Court decision on affirmative action

How the Dana

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

STAT Virtual Event: How to Increase Diversity in Clinical Trials

focus

Shingles, which affected Dianne Feinstein, is on the rise

How the Dana

STAT Summit: The economic case for universal basic health care

STAT Readout Newsletter: Biotech news today

Roche drug slashes death risk in early

Readout LOUD podcast: Live from the 2023 STAT Summit

hotspot

leisure time

leisure time

leisure time